Immunovant, a biotechnology company known for its innovative treatments for autoimmune diseases, has recently announced a significant shift in its development strategy. Despite late-stage successes with its experimental drug batoclimab, the company has decided to momentarily hold back on seeking
Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder that significantly impacts both liver and lung function, resulting in a rare but severe health burden. In an ambitious and promising development, Prime Medicine is leveraging its innovative gene editing technology to address this
Ivan Kairatov is a Biopharma expert with deep knowledge of tech and innovation in the industry and experience in research and development. Today, we are discussing Med-Life Discoveries (MLD), their mission, and the promising results of their Phase I study on PPI-1011, a synthetic plasmalogen
Research on cranial osteopathic manipulation for TBI treatment has received $2.17 million from the NIH. This funding supports Virginia Tech’s Pamela VandeVord and Edward Via College of Osteopathic Medicine’s Gunnar Brolinson. Their collective efforts aim to explore innovative non-invasive str
Pancreatic cancer, recognized for its aggressive nature and limited treatment options, remains one of the most challenging malignancies to manage. Researchers at the Perelman School of Medicine, University of Pennsylvania, and Penn Medicine's Abramson Cancer Center have recently unveiled
The ongoing opioid crisis has affected countless lives, leaving individuals and families grappling with addiction and its devastating consequences. Amid this turmoil, researchers funded by the National Institutes of Health (NIH) have been diligently working on a novel solution that could change the
